Showing results (1-10 of 220) with videos related to
Sort By:
Pageof 22
Expert Opinion on Investigational Drugs|November 4, 2000
Small molecule alpha(v) integrin antagonists: novel anticancer agentsJ S Kerr, A M Slee, S A MousaDrug News & Perspectives|June 24, 2003
Alpha(v)beta(3) integrin in angiogenesis and restenosisJ S Kerr, S A Mousa, A M SleeJournal of Cellular Biochemistry|October 13, 2000
Antiangiogenesis efficacy of nitric oxide donorsJ A Powell, S N Mohamed, J S Kerr, et al.Anticancer Research|June 16, 1999
Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitorsJ S Kerr, R S Wexler, S A Mousa, et al.Anticancer Research|May 16, 2000
The hollow fiber assay: continued characterization with novel approachesL A Hall, C M Krauthauser, R S Wexler, et al.Anticancer Research|June 9, 2001
Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assayC M Krauthauser, L A Hall, R S Wexler, et al.The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3S A Mousa, J M Bozarth, W Lorelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Tumor biology: use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatmentsE J Wexler, E M Gravallese, P M Czerniak, et al.Infection and Immunity|June 1, 1979
Phosphoenolpyruvate-dependent sucrose phosphotransferase activity in Streptococcus mutans NCTC 10449A M Slee, J M TanzerSeminars in Thrombosis and Hemostasis|September 30, 2000
Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: implications for management of vascular disordersS A MousaPageof 22